Neuronetics, Inc. (NASDAQ:STIM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year [Yahoo! Finance]
Neuronetics, Inc. (STIM)
Last neuronetics, inc. earnings: 3/3 06:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
It was a respectable set of results; while revenues of US$17m were in line with analyst predictions, statutory losses were 13% smaller than expected, with Neuronetics losing US$0.27 per share. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year. Check out our latest analysis for Neuronetics Following the latest results, Neuronetics' four analysts are now forecasting revenues of US$79.1m in 2024. This would be a meaningful 8.1% improvement in revenue compared to the last 12 months. Losses are expected to hold steady at around US$0.92. Before this earnings announcement, the analysts had been modelling revenues of US$79.1m and losses of US$0.93 per share in 2024. The consensus price target was unchanged at US$7.00, suggesting t
Show less
Read more
Impact Snapshot
Event Time:
STIM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STIM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STIM alerts
High impacting Neuronetics, Inc. news events
Weekly update
A roundup of the hottest topics
STIM
News
- Humana Is First Commercial Payer to Address TMS Therapy Coverage for AdolescentsGlobeNewswire
- Neuronetics, Inc. (NASDAQ: STIM) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.MarketBeat
- Neuronetics: Reality Set In [Seeking Alpha]Seeking Alpha
- Neuronetics, Inc. (NASDAQ:STIM) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Neuronetics Reports Record First Quarter 2024 Financial and Operating Results [Yahoo! Finance]Yahoo! Finance
STIM
Earnings
- 5/7/24 - Beat
STIM
Sec Filings
- 5/7/24 - Form 10-Q
- 5/7/24 - Form 8-K
- 5/7/24 - Form 8-K
- STIM's page on the SEC website